...
首页> 外文期刊>Neurosurgery >Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.
【24h】

Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.

机译:巨大垂体腺瘤的外科治疗:连续95例患者的策略和结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Giant pituitary adenomas, defined as those measuring at least 4 cm in maximum diameter, are a therapeutic challenge. We report our experience in a large, consecutive series of patients with giant adenomas. METHODS: Between 1990 and 2004, 95 patients with a giant pituitary adenomas underwent surgery at our department. Nonfunctioning pituitary adenoma was the most frequent type (n = 70; 73.7%), whereas hormone-secreting adenomas numbered only 25 (26.3%). The mean age at the time of surgery (+/-standard error of the mean) was 48.4 +/- 1.5 years; there were 66 men (69.5%) and 29 women (20.5%). RESULTS: In total, 111 surgical procedures were performed. Of these, 85 approaches (76.6%) were transsphenoidal and 26 (23.4%) were transcranial. Visual improvement occurred in 59 of the 79 patients with preoperative defect who could be evaluated after surgery (74.7%). Radical tumor excision was obtained in 14 patients (14.7%). Adjuvant medical and radiation therapies led to 74.5% (95% confidence interval,62.7-86.4%) control of tumor growth at 5 years. This was not different in patients with nonfunctioning pituitary adenomas compared with patients with hormone-secreting tumors. In the subgroup of patients with nonfunctioning pituitary adenomas, radiation therapy had a protective role against tumor growth (P < 0.01). CONCLUSION: Maximal surgical removal of giant adenomas through the transsphenoidal or transcranial approach, or both, aimed to relieve compression of the optic pathway and reduce tumor volume as much as possible, offers the best chances to control the tumor when followed with adjuvant medical and radiation therapies.
机译:目的:垂体腺瘤定义为最大直径至少4 cm的垂体腺瘤是治疗上的挑战。我们报告了我们在一系列连续的巨大腺瘤患者中的经验。方法:在1990年至2004年之间,我们部门对95例巨大的垂体腺瘤患者进行了手术。非功能性垂体腺瘤是最常见的类型(n = 70; 73.7%),而分泌激素的腺瘤仅占25(26.3%)。手术时的平均年龄(平均值的+/-标准误差)为48.4 +/- 1.5岁;男66名(69.5%),女29名(20.5%)。结果:总共进行了111例外科手术。其中,经蝶窦入路85例(76.6%),经颅颅入路26例(23.4%)。术前可评估的79例术前缺陷患者中有59例发生了视觉改善(74.7%)。 14例患者(14.7%)获得了根治性肿瘤切除。辅助药物和放射疗法导致5年时肿瘤生长的控制率为74.5%(置信区间为95%,62.7-86.4%)。垂体腺瘤无功能的患者与荷尔蒙分泌肿瘤的患者相比没有什么不同。在无功能垂体腺瘤的患者亚组中,放射治疗对肿瘤生长具有保护作用(P <0.01)。结论:通过蝶骨或经颅入路或两者兼有的方式最大程度地手术切除巨大的腺瘤,旨在减轻视神经通路的压迫并尽可能减少肿瘤的体积,在辅佐药物和放射治疗后提供了控制肿瘤的最佳机会疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号